Comments include: ETON, HUM, LNG, MO, MPC, MS, & SYRE.
| ETON Eton Pharmaceuticals, Inc. ($56.46) - Drugs - ETON rose over 20% Friday to break a double top at $54 before climbing to $58 intraday. This 4 for 5'er moved to a positive trend in February and has been on an RS buy signal against the market since March. ETON has not been able to give two consecutive buy signals since the summer, so it would be ideal to see further confirmation of demand controlling the price action. Initial support is seen at $48. Further overhead resistance may be seen at $60. |
| HUM Humana Inc. ($432.98) - Healthcare - HUM climbed Friday to break a double top at $440 after the company's earnings release. This 5 for 5'er moved to a positive trend in April and sits in the top half of the healthcare sector RS matrix. The weight of the technical evidence is favorable and improving. Initial support is seen at $400. Note that further resistance may be seen at $456. |
| LNG Cheniere Energy, Inc. ($279.14) - Oil Service - LNG fell to a sell signal and a negative trend Friday when it broke a double bottom at $276, where it now sits against support. The outlook for the stock remains positive, however, as even with the negative trend change LNG is a 4 for 5'er. |
| MO Altria Group Inc. ($76.12) - Food Beverages/Soap - Shares of MO broke a double bottom at $75, moving to a sell signal. The 4 for 5'er recently regained near-term market relative strength, moving up to buy territory as 4 for 5'er. Additionally, a reversal back into a column of Xs could mark the start of shakeout pattern. Overall, the name remains a more attractive name in the consumer staples space. |
| MPC Marathon Petroleum Corp. ($374.51) - Oil Service - MPC fell to a sell signal Friday when it broke a spread quintuple bottom at $376. The outlook for the stock remains positive despite Friday's move as MPC is a 4 for 5'er. From here, the next level of support sits at $348 but beyond that level MPC shows no additional support until $292. |
| MS Morgan Stanley ($181.44) - Wall Street - MS shares moved lower today to break a double bottom at $182 to mark its first sell signal and enter a negative trend. This 2 for 5'er has been on an RS buy signal versus the market since June 2013. MS shares are trading below the middle of their ten-week trading band. From here, support is offered at $180 and $178. |
| SYRE Spyre Therapeutics Inc. ($103.86) - Biomedics/Genetics - SYRE moved higher Friday to complete a shakeout patter with a triple top break at $102 before reaching $104 intraday. This 3 for 5'er moved to a positive trend last month and sits in the top quintile of the biomedics/genetics sector RS matric. The weight of the technical evidence is favorable and improving. Initial support sits at $93 with further support at $89. Further overhead resistance may be seen at $110. |
